In April, Boehringer Ingelheim announced a multifaceted plan to help fight COVID-19, which included collaborating with academic researchers to find potential treatments. Now one of those research programs has uncovered 28 antibodies that the company plans to move into further testing.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,